Skip to main content
![Creative Commons 'BY' version 4.0 license]()
6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-Dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding
